Justin Stebbing

Justin Stebbing is a prominent British clinician-scientist specializing in oncology and cancer research.12 He was the first NIHR Research Translational Professor at Imperial College London, focusing on bridging the gap between laboratory discoveries and personalized cancer treatments.34

Stebbing's career highlights include:

1. Current positions:

   • Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge1
   • Co-Editor-in-Chief of the journal Oncogene12
   • Visiting Professor of Cancer Medicine and Oncology at Imperial College London2

2. Education and training:

   • Graduated from Trinity College, Oxford with a first-class degree in medicine1
   • Trained at The Johns Hopkins Hospital in Baltimore, USA1
   • Completed training at the Royal Marsden and St Barts Hospitals1

3. Research contributions:

   • Published over 700 peer-reviewed papers with an h-index of 89 on Google Scholar2
   • Investigated the link between immunology, tumors, and viruses1
   • Led studies on antiretrovirals and their impact on tumorigenesis1
   • Identified LMTK3 as an oncogene and therapeutic target in breast cancer2
   • During the COVID-19 pandemic, used AI to identify baricitinib as a potential treatment2

4. Clinical practice:

   • Previously practiced with Imperial College Healthcare NHS Trust2
   • Currently practices with the private Phoenix Hospital Group, specializing in solid malignancies2

Stebbing's work has garnered significant recognition, including his election to the American Society for Clinical Investigation and his role in founding the charity Action Against Cancer to support his research.12